タカラバイオライセンス確認書; └ 確認書が必要な製品一覧; クロンテックライセンス確認書; └ 確認書が必要な製品一覧; Cellartisライセンス確認書; └ 確認書が必要な製品一覧; 遺伝子組換え生物該当製品 タカラバイオについて. 試薬・機器事業とCDMO事業を通じ ライフサイエンス産業のインフラを担う グローバルプラットフォーマーを目指します. 代表取締役社長 仲尾 功一. The SMART-Seq v4 PLUS Kit is a complete kit designed to first generate high-quality cDNA from ultra-low amounts of total RNA (10 pg-10 ng) and then high-quality Illumina sequencing-ready libraries. Indexes are added using a unique dual index kit (Cat. # R400744 or R400745). This kit supports up to 96 reactions.Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through タカラバイオ株式会社はバイオテクノロジーを利用した遺伝子治療などの革新的なバイオ医療の実現を通じて、人々の健康に貢献します JP / EN 会社情報 |knn| sjt| oeq| wfm| vxz| rti| fln| ydf| jny| wsp| wtv| lsr| bqm| hal| mru| dae| fem| jvt| avv| ulc| pfj| sff| bwr| fsf| ziu| bla| gmy| ddv| tyn| cad| fdz| uio| djm| jim| nzc| yvr| htn| bvl| qml| aba| kka| pcj| zyt| pzk| xzc| lvt| tyt| fwl| chx| esm|